When Should We Start Sodium-Glucose Co-transporter Inhibitors in Patients with Heart Failure? The Importance of Early Intervention.

Iguchi, Moritake; Wada, Hiromichi; Martínez, Felipe; Hasegawa, Koji

Iguchi, Moritake; Wada, Hiromichi; Martínez, Felipe; Hasegawa, Koji.

Afiliação

Iguchi M; Department of Cardiac Rehabilitation, National Hospital Organization Kyoto Medical Center Kyoto, Japan.
Wada H; Division of Translational Research, National Hospital Organization Kyoto Medical Center Kyoto, Japan.
Martínez F; Córdoba National University Córdoba, Argentina.
Hasegawa K; Division of Translational Research, National Hospital Organization Kyoto Medical Center Kyoto, Japan.

Eur Cardiol ; 18: e41, 2023.

Article em En | MEDLINE | ID: mdl-37456773

Palavras-chave

Heart failure; SGLT2 inhibitor; pharmacotherapy

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Eur Cardiol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google